Association between functional EGF+61 polymorphism and glioma risk.
Clin Cancer Res.
2007 May 1;13(9):2621-6. doi: 10.1158/1078-0432.CCR-06-2606. PubMed PMID:
17473192.
Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma.
Cancer Res.
2010 Jan 15;70(2):453-62. doi: 10.1158/0008-5472.CAN-09-2189. Epub 2010 Jan 12. PubMed PMID:
20068170; PubMed Central PMCID:
PMC2849935.
Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study.
Oncol Rep.
2010 Jun;23(6):1655-62. doi: 10.3892/or_00000808. PubMed PMID:
20428822.
Association between EGF +61A/G polymorphism and gastric cancer in Caucasians.
World J Gastroenterol.
2011 Jan 28;17(4):488-92. doi: 10.3748/wjg.v17.i4.488. PubMed PMID:
21274378; PubMed Central PMCID:
PMC3027015.
Impact of EGFR genetic variants on glioma risk and patient outcome.
Cancer Epidemiol Biomarkers Prev.
2011 Dec;20(12):2610-7. doi: 10.1158/1055-9965.EPI-11-0340. Epub 2011 Sep 29. PubMed PMID:
21960689.
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
Neuro Oncol.
2011 Dec;13(12):1331-8. doi: 10.1093/neuonc/nor130. Epub 2011 Sep 6. PubMed PMID:
21896554; PubMed Central PMCID:
PMC3223090.
Insights into angiogenesis in non-small cell lung cancer: molecular mechanisms, polymorphic genes, and targeted therapies.
Recent Pat Anticancer Drug Discov.
2012 Jan;7(1):118-31. doi: 10.2174/157489212798357994. Review. PubMed PMID:
21854359.
Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.
Tumour Biol.
2012 Oct;33(5):1341-8. doi: 10.1007/s13277-012-0382-7. Epub 2012 Mar 29. PubMed PMID:
22457050.
Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids.
Mol Psychiatry.
2012 Dec;17(12):1295-305. doi: 10.1038/mp.2011.126. Epub 2011 Oct 4. PubMed PMID:
21968930.
In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models.
Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology. 2013 May; (15):1621. doi: 10.1007/s11051-013-1621-6.
Molecular prognostic factors in glioblastoma: state of the art and future challenges.
CNS Oncol.
2013 Nov;2(6):495-510. doi: 10.2217/cns.13.48. Review. PubMed PMID:
25054820; PubMed Central PMCID:
PMC6136097.
Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication.
Epigenetics.
2015;10(11):1033-43. doi: 10.1080/15592294.2015.1103578. PubMed PMID:
26488939; PubMed Central PMCID:
PMC4844211.
A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide.
Oncotarget.
2015 Apr 10;6(10):7657-74. doi: 10.18632/oncotarget.3150. PubMed PMID:
25762636; PubMed Central PMCID:
PMC4480707.
MicroRNA-375 plays a dual role in prostate carcinogenesis.
Clin Epigenetics.
2015;7:42. doi: 10.1186/s13148-015-0076-2. eCollection 2015. PubMed PMID:
25977730; PubMed Central PMCID:
PMC4431534.
Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities.
Front Cell Neurosci.
2015;9:249. doi: 10.3389/fncel.2015.00249. eCollection 2015. Review. PubMed PMID:
26217178; PubMed Central PMCID:
PMC4499760.
Impact of TGF-β1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis.
Tumour Biol.
2015 Aug;36(8):6525-32. doi: 10.1007/s13277-015-3343-0. Epub 2015 Mar 27. PubMed PMID:
25813152.
Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models.
Genom Data.
2015 Sep;5:54-8. doi: 10.1016/j.gdata.2015.05.010. eCollection 2015 Sep. PubMed PMID:
26484224; PubMed Central PMCID:
PMC4583997.
Variant Rett syndrome in a girl with a pericentric X-chromosome inversion leading to epigenetic changes and overexpression of the MECP2 gene.
Int J Dev Neurosci.
2015 Nov;46:82-7. doi: 10.1016/j.ijdevneu.2015.07.010. Epub 2015 Aug 10. PubMed PMID:
26287660.
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Carcinogenesis.
2016 Feb;37(2):169-176. doi: 10.1093/carcin/bgv251. Epub 2015 Dec 30. PubMed PMID:
26717998.
Understanding TERT Promoter Mutations: A Common Path to Immortality.
Mol Cancer Res.
2016 Apr;14(4):315-23. doi: 10.1158/1541-7786.MCR-16-0003. Epub 2016 Mar 3. Review. PubMed PMID:
26941407; PubMed Central PMCID:
PMC4852159.
Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.
Oncotarget.
2016 Jul 19;7(29):46335-46353. doi: 10.18632/oncotarget.10114. PubMed PMID:
27331625; PubMed Central PMCID:
PMC5216802.
Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer.
Oncotarget.
2016 Aug 16;7(33):53018-53028. doi: 10.18632/oncotarget.10061. PubMed PMID:
27323813; PubMed Central PMCID:
PMC5288165.
Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis.
J Neurooncol.
2017 Mar;132(1):27-34. doi: 10.1007/s11060-016-2345-0. Epub 2017 Jan 12. PubMed PMID:
28083786.
A semiautomated microfluidic platform for real-time investigation of nanoparticles' cellular uptake and cancer cells' tracking.
Nanomedicine (Lond).
2017 Mar;12(6):581-596. doi: 10.2217/nnm-2016-0344. Epub 2017 Feb 10. PubMed PMID:
28186438.
Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.
Cell Commun Signal.
2017 Oct 2;15(1):37. doi: 10.1186/s12964-017-0194-x. PubMed PMID:
28969644; PubMed Central PMCID:
PMC5625790.
Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
J Transl Med.
2017 Oct 2;15(1):200. doi: 10.1186/s12967-017-1303-8. PubMed PMID:
28969635; PubMed Central PMCID:
PMC5625623.
Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis.
Cell Rep.
2017 Dec 5;21(10):2842-2854. doi: 10.1016/j.celrep.2017.11.034. PubMed PMID:
29212030; PubMed Central PMCID:
PMC5732321.
SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.
Epigenetics.
2017;12(12):1057-1064. doi: 10.1080/15592294.2017.1385685. Epub 2018 Jan 22. PubMed PMID:
29099276; PubMed Central PMCID:
PMC5810786.
Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival.
Biomark Med.
2018 Mar;12(3):257-264. doi: 10.2217/bmm-2017-0258. Epub 2018 Feb 13. PubMed PMID:
29436234.
The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma.
Oncotarget.
2018 Mar 20;9(21):15740-15756. doi: 10.18632/oncotarget.24597. eCollection 2018 Mar 20. PubMed PMID:
29644006; PubMed Central PMCID:
PMC5884661.
A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97.
Clin Epigenetics.
2018;10:40. doi: 10.1186/s13148-018-0475-2. eCollection 2018. PubMed PMID:
29599847; PubMed Central PMCID:
PMC5870254.
WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma.
Theranostics.
2018;8(17):4805-4823. doi: 10.7150/thno.25025. eCollection 2018. PubMed PMID:
30279739; PubMed Central PMCID:
PMC6160775.
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.
Cancer Cell.
2018 Sep 10;34(3):513-528.e8. doi: 10.1016/j.ccell.2018.08.003. PubMed PMID:
30205050; PubMed Central PMCID:
PMC6135086.
The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas.
Biochimie.
2018 Dec;155:59-66. doi: 10.1016/j.biochi.2018.07.008. Epub 2018 Jul 19. Review. PubMed PMID:
30031037.
The cell secretome in personalized and regenerative medicine.
Biochimie.
2018 Dec;155:1. doi: 10.1016/j.biochi.2018.11.004. Epub 2018 Nov 9. PubMed PMID:
30419261.
Large expert-curated database for benchmarking document similarity detection in biomedical literature search.
Database. 2019 October; 2019. doi: https://doi.org/10.1093/database/baz085.
Serum lactate levels are associated with glioma malignancy grade.
Clin Neurol Neurosurg.
2019 Nov;186:105546. doi: 10.1016/j.clineuro.2019.105546. Epub 2019 Oct 1. PubMed PMID:
31605893.
Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
J Transl Med.
2019 Dec 30;17(1):435. doi: 10.1186/s12967-019-02193-y. PubMed PMID:
31888645; PubMed Central PMCID:
PMC6936051.
HOX gene cluster (de)regulation in brain: from neurodevelopment to malignant glial tumours.
Cell Mol Life Sci.
2020 Apr 1;. doi: 10.1007/s00018-020-03508-9. [Epub ahead of print] Review. PubMed PMID:
32239260.
Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion.
Cancers (Basel).
2020 Apr 25;12(5). doi: 10.3390/cancers12051066. PubMed PMID:
32344886; PubMed Central PMCID:
PMC7281198.
A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis.
Mol Oncol.
2020 Jun;14(6):1224-1241. doi: 10.1002/1878-0261.12633. Epub 2020 May 6. PubMed PMID:
31923345; PubMed Central PMCID:
PMC7266278.
MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples.
J Exp Clin Cancer Res.
2020 Jun 1;39(1):98. doi: 10.1186/s13046-020-01600-3. PubMed PMID:
32487203; PubMed Central PMCID:
PMC7323611.
Unravelling the anticancer potential of functionalized chromeno[2,3-b]pyridines for breast cancer treatment.
Bioorg Chem.
2020 Jul;100:103942. doi: 10.1016/j.bioorg.2020.103942. Epub 2020 May 17. PubMed PMID:
32450388.
Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting.
Int J Mol Sci.
2020 Jul 25;21(15). doi: 10.3390/ijms21155278. Review. PubMed PMID:
32722427; PubMed Central PMCID:
PMC7432229.
What would you like to do?